ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hospitalist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,606Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 28

$479K Total Retail Price of All Prescriptions

Rank: 3 out of 28

409 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 409 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

24% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

4% of this provider’s 7,113 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
WARFARIN SODIUM 305 255 1 1
FUROSEMIDE 304 242 2 5
HYDROCODONE-ACETAMINOPHEN 301 216 S3 3 2
METOPROLOL TARTRATE 262 165 4 6
OMEPRAZOLE 235 185 5 4
LISINOPRIL 234 177 6 3
POTASSIUM CHLORIDE 207 169 7 15
AMLODIPINE BESYLATE 203 179 8 9
SIMVASTATIN 177 136 9 7
DONEPEZIL HCL 169 128 10 27
NAMENDA 151 147 11 42
CITALOPRAM HBR 142 74 12 19
OXYCODONE-ACETAMINOPHEN 135 113 S2 13 33
LEVOTHYROXINE SODIUM 128 111 14 8
TRAZODONE HCL 124 72 15 50
BUSPIRONE HCL 122 73 16 51
CLONIDINE HCL 120 93 17 53
DIGOXIN 120 104 17 28
CIPROFLOXACIN HCL 116 82 19 55
QUETIAPINE FUMARATE 114 74 20 31
NOVOLOG 113 82 21 36
DIVALPROEX SODIUM 113 103 21 34
CLOPIDOGREL 112 81 23 24
TAMSULOSIN HCL 110 98 24 57
RISPERIDONE 106 81 25 59
METFORMIN HCL 105 58 26 18
SERTRALINE HCL 99 81 27 12
LANTUS 94 55 28 44
GLYBURIDE 91 76 R 29 65
MEGESTROL ACETATE 90 76 R 30 43
HYDROCHLOROTHIAZIDE 79 55 31 25
RANITIDINE HCL 78 45 32 70
ISOSORBIDE MONONITRATE ER 77 53 33 38
PLAVIX 76 49 34 34
RISPERDAL CONSTA 74 0 35 74
POLYETHYLENE GLYCOL 3350 73 47 36 45
GABAPENTIN 68 41 37 14
ROPINIROLE HCL 67 67 38 79
BENZTROPINE MESYLATE 67 28 R 38 79
METOCLOPRAMIDE HCL 66 44 40 52
FLUOXETINE HCL 63 50 41 82
DIVALPROEX SODIUM ER 62 50 42 83
PAROXETINE HCL 60 51 43 49
CARBIDOPA-LEVODOPA 60 39 43 85
TRAMADOL HCL 59 58 45 30
LEVETIRACETAM 59 57 45 86
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 42 47 87
ESCITALOPRAM OXALATE 57 57 48 91
KLOR-CON M10 57 11 48 47
FAMOTIDINE 56 55 50 56
MIRTAZAPINE 56 46 50 45
KLOR-CON M20 54 49 52 95
LEVEMIR 52 25 53 60
NYSTATIN 52 33 53 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.